Literature DB >> 25846483

Inverse association between serum total bilirubin levels and diabetic peripheral neuropathy in patients with type 2 diabetes.

Eun Sook Kim1,2, Sung Won Lee3,2, Eun Young Mo1,2, Sung Dae Moon4,5, Je Ho Han6,7.   

Abstract

Several studies have suggested that bilirubin, a potent innate antioxidant, plays a protective role against cardiovascular and microvascular disease. This study investigated the association between serum concentrations of total bilirubin (TB) and the presence of diabetic peripheral neuropathy (DPN) in Korean diabetic patients. This cross-sectional study involved 1207 patients aged more than 30 years with type 2 diabetes. DPN was assessed according to clinical symptoms and physical examinations using Michigan Neuropathy Screening Instrument examination score, 10-g monofilament sensation, and current perception threshold. The subjects were stratified into gender-specific tertiles based on TB values, and the relationship between the TB values and DPN was analyzed. Compared with patients within the lowest TB tertile, those with higher TB levels consisted of patients with shorter duration of diabetes, lower HbA1c, better renal function, and less autonomic neuropathy, retinopathy, and albuminuria. Serum TB levels were inversely associated with DPN. In multivariate analysis for the development of DPN after adjusting for potential confounding factors including retinopathy, albuminuria, and autonomic neuropathy, the TB levels were inversely associated with the presence of DPN, both as a continuous variable [odds ratio (OR) per log standard deviation (SD) 0.79; 95% confidence interval (CI) 0.65-0.97; P = 0.022] and when categorized in tertiles (the highest vs. the lowest tertile; OR 0.63; 95% CI 0.40-0.99; P = 0.046). Low serum bilirubin levels are significantly associated with DPN, independently of classic risk factors and other microvascular complications. Further investigation is necessary to determine whether serum bilirubin has a prognostic significance on DPN.

Entities:  

Keywords:  Bilirubin; Diabetic peripheral neuropathy; Type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 25846483     DOI: 10.1007/s12020-015-0583-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  34 in total

1.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

Review 2.  Diagnostics and treatment of the diabetic foot.

Authors:  Jan Apelqvist
Journal:  Endocrine       Date:  2012-02-25       Impact factor: 3.633

3.  Letter: Idiopathic hyperbilirubinemia and phototherapy--evidence suggesting a decreased incidence of kernicterus.

Authors:  C Petrich; U Gobel
Journal:  Pediatrics       Date:  1974-11       Impact factor: 7.124

4.  Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Cinzia Valenti; Adriana Garzaniti; Gabriele Pelissero; Fabrizio Salvucci; Pietro Gallotti; Arturo Pujia; Colomba Falcone; Sebastiano B Solerte; Andrea Giustina
Journal:  Endocrine       Date:  2011-08-23       Impact factor: 3.633

5.  High serum bilirubin levels and diabetic retinopathy: the Hisayama Study.

Authors:  Miho Yasuda; Yutaka Kiyohara; Jie Jin Wang; Satoshi Arakawa; Koji Yonemoto; Yasufumi Doi; Toshiharu Ninomiya; Tatsuro Ishibashi
Journal:  Ophthalmology       Date:  2011-05-20       Impact factor: 12.079

6.  Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus.

Authors:  N Papanas; N Katsiki; K Papatheodorou; M Demetriou; D Papazoglou; T Gioka; E Maltezos
Journal:  Angiology       Date:  2011-02-08       Impact factor: 3.619

7.  Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.

Authors:  K H Chan; R L O'Connell; D R Sullivan; L S Hoffmann; K Rajamani; M Whiting; M W Donoghoe; M Vanhala; A Hamer; B Yu; R Stocker; M K C Ng; A C Keech
Journal:  Diabetologia       Date:  2013-01-17       Impact factor: 10.122

8.  Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy.

Authors:  A J Boulton; F A Gries; J A Jervell
Journal:  Diabet Med       Date:  1998-06       Impact factor: 4.359

9.  Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitus.

Authors:  N Papanas; M Demetriou; N Katsiki; K Papatheodorou; D Papazoglou; T Gioka; S Kotsiou; E Maltezos; D P Mikhailidis
Journal:  Exp Diabetes Res       Date:  2011-09-15

10.  Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes.

Authors:  Seok Man Son
Journal:  Diabetes Metab J       Date:  2012-06-14       Impact factor: 5.376

View more
  17 in total

1.  Serum bilirubin levels are negatively associated with diabetic retinopathy in patients with type 1 diabetes and normal renal function.

Authors:  Tomislav Bulum; Martina Tomić; Lea Duvnjak
Journal:  Int Ophthalmol       Date:  2017-05-18       Impact factor: 2.031

2.  Inverse Association between Serum Bilirubin Levels and Retinopathy in Patients with Type 2 Diabetes Mellitus.

Authors:  Divya Karuppannasamy; Raghuram Venkatesan; Lekha Thankappan; Raghuram Andavar; Sundar Devisundaram
Journal:  J Clin Diagn Res       Date:  2017-02-01

3.  Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients.

Authors:  Yu-Ming Hu; Li-Hua Zhao; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Feng Xu; Tong Chen; Xue-Qin Wang; Ai-Song Guo; Jian-An Li; Jian-Bin Su
Journal:  Endocrine       Date:  2018-02-06       Impact factor: 3.633

4.  Effect of bilirubin concentration on the risk of diabetic complications: A meta-analysis of epidemiologic studies.

Authors:  Bo Zhu; Xiaomei Wu; Yifei Bi; Yang Yang
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

5.  Inverse Relationship Between Serum Bilirubin Levels and Diabetic Foot in Chinese Patients with Type 2 Diabetes Mellitus.

Authors:  Jifan Chen; Jian Wang; Xingxing Zhang; Hong Zhu
Journal:  Med Sci Monit       Date:  2017-12-14

6.  The Association between Serum Bilirubin Level and Electrochemical Skin Conductance in Chinese Patients with Type 2 Diabetes.

Authors:  Fei Mao; Xiaoming Zhu; Bin Lu; Yiming Li
Journal:  Int J Endocrinol       Date:  2018-03-07       Impact factor: 3.257

7.  Association between Hemoglobin Levels and Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes: A Cross-Sectional Study Using Electronic Health Records.

Authors:  Jun Yang; Pi-Jun Yan; Qin Wan; Hua Li
Journal:  J Diabetes Res       Date:  2017-06-21       Impact factor: 4.011

8.  Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.

Authors:  Mark F McCarty
Journal:  Healthcare (Basel)       Date:  2017-03-14

9.  Differential impact of serum total bilirubin level on cerebral atherosclerosis and cerebral small vessel disease.

Authors:  Jonguk Kim; Seung-Jae Yoon; Min-Hee Woo; Sang-Heum Kim; Nam-Keun Kim; Jinkwon Kim; Ok-Joon Kim; Seung-Hun Oh
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

10.  HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients.

Authors:  Jian-Bin Su; Li-Hua Zhao; Xiu-Lin Zhang; Hong-Li Cai; Hai-Yan Huang; Feng Xu; Tong Chen; Xue-Qin Wang
Journal:  Cardiovasc Diabetol       Date:  2018-03-29       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.